03737 中智藥業
按盘价 
0.900 +0.010 (+1.124%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | 8.876% | 6.259% | 3.541% | 10.258% | 10.008% |
| 股东资金回报率 (%) | 15.869% | 11.189% | 6.065% | 17.496% | 15.605% |
| 资本运用回报率 (%) | 13.748% | 9.300% | 5.094% | 14.815% | 13.362% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 59.427% | 58.726% | 60.775% | 61.800% | 62.189% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 15.150% | 12.580% | 8.577% | 16.346% | 16.040% |
| 税前边际利润率 (%) | 10.127% | 7.155% | 3.539% | 10.426% | 11.618% |
| 纯利率 (%) | 7.941% | 5.826% | 2.985% | 8.637% | 8.545% |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 1.436 X | 1.492 X | 1.712 X | 1.821 X | 1.986 X |
| 速动比率 (X) | 0.894 X | 1.050 X | 1.177 X | 1.312 X | 1.515 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 41.241% | 46.357% | 40.873% | 42.151% | 40.386% |
| 总债项 / 总资产比率 (%) | 9.754% | 9.111% | 11.531% | 13.228% | 9.957% |
| 净债项 / 总资产比率 (%) | 0.585% | -11.206% | -3.782% | -7.471% | -19.744% |
| 总债项 / 股东资金比率 (%) | 16.677% | 17.035% | 19.554% | 22.910% | 16.703% |
| 长期债项 / 股东资金比率 (%) | 9.468% | 9.434% | 8.971% | 8.927% | 8.379% |
| 净债项 / 股东资金比率 (%) | 1.000% | -20.953% | -6.413% | -12.940% | -33.119% |
| 净现金 / (债项) ($) | (1.05千万) | 2.10亿 | 5.76千万 | 1.06亿 | 2.53亿 |
| 每股净现金 / (债项) ($) | (0.012) | 0.243 | 0.067 | 0.126 | 0.301 |
| 总债项 / 资本运用比率 (%) | 14.768% | 14.935% | 17.174% | 20.095% | 14.854% |
| 利息盈利率 (X) | 27.383 X | 20.932 X | 9.731 X | 33.047 X | 39.917 X |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 143.275日 | 143.105日 | 137.243日 | 132.900日 | 135.944日 |
| 应收贸易帐周转率日数 (日) | 56.941日 | 60.481日 | 60.257日 | 59.835日 | 55.041日 |
| 应付贸易帐周转率日数 (日) | 33.899日 | 31.045日 | 24.166日 | 24.434日 | 25.796日 |
| 备注： | 实时报价更新时间为06/11/2024 11:46 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB 83,440 |
| 增长率 | -38.147% |
| 每股盈利/(亏损) | RMB 0.099 |
| 每股账面资产净值 (¥) | RMB 1.282 |